Richter BioLogics Tech Stack

GMP-compliant contract manufacturer of microbial biopharmaceuticals

Biotechnology Research Hamburg 201–500 employees Founded 1987 Public Company

Richter BioLogics operates three cGMP production facilities and one development center in Germany, specializing in bacterial and yeast-derived therapeutics—proteins, antibodies, plasmid DNA, and vaccines. The company is mid-expansion: it recently added 300L and 1500L production lines at its Bovenau site and expanded Hamburg's development facility. The hiring mix (manufacturing and quality roles dominate; engineering and research present but smaller) reflects operational scaling rather than platform innovation—the focus is capacity and compliance, not new tooling. Current pain points cluster around cross-site process harmonization and capacity planning as the expanded footprint comes online.

Tech Stack 18 technologies

Core StackSAP Power BI SAP S/4HANA Microsoft Office Excel Word PowerPoint LIMS AWS Database Migration Service qPCR Veeva Vault SAP R/3 Siemens S7-1200 WinCC Visio PROFINET Profibus Modbus

What Richter BioLogics Is Building

◆Challenges

Ensuring gmp compliance
Optimizing lab infrastructure and processes
Cross-site coordination
Cross-site process harmonization
Capacity planning for cdmo projects
Staffing gap due to parental leave
Managing international client projects
Handling regulatory audits
Migrating external accounting to inhouse
Improving accounting process efficiency

▲Active Projects

Chromatographic method validation
Lab infrastructure optimization
Lab expansion
Audit readiness
Cdmo projects
Stability studies
Sample analysis
International client quality projects
Client audits
Regulatory inspections

Hiring Activity

Accelerating30 roles · 25 in 30d

Department

Manufacturing

Quality

Engineering

Research

Finance

Sales

Seniority

Mid

Intern

Junior

Senior

Company intelligence

Find more companies like Richter BioLogics by tech stack, pain points and active projects

Get started free

About Richter BioLogics

Richter BioLogics is a publicly traded contract development and manufacturing organization (CDMO) founded in 1987 and based in Hamburg. The company manufactures biopharmaceuticals using microbial fermentation—bacteria and yeast—for pharmaceutical and biotech clients from early clinical through commercial supply. The service portfolio spans strain development, process development, analytical method validation, and in-house quality control and release. With three production facilities plus a dedicated development center, Richter BioLogics serves global pharmaceutical companies requiring GMP-compliant supply for proteins, antibodies, plasmid DNA vaccines, and other microbial-derived products. The company employs 201–500 people and is actively hiring across manufacturing, quality, and engineering roles in Germany.

HeadquartersHamburg

Company Size201–500 employees

Founded1987

Hiring MarketsGermany

Frequently Asked Questions

What is Richter BioLogics' manufacturing focus?

Richter BioLogics specializes in GMP-compliant microbial fermentation—bacteria and yeast-derived biopharmaceuticals, including proteins, antibodies (VHH, Fab, nanobodies), plasmid DNA, and vaccines. Three production facilities handle clinical and commercial supply; one development center supports process development and scale-up.

Is Richter BioLogics currently expanding capacity?

Yes. The company recently added 300L and 1500L production lines at its Bovenau site and expanded its Hamburg development facility. Active hiring spans manufacturing, quality, and engineering roles to support the expanded footprint.

What tech stack does Richter BioLogics use?

SAP (R/3 and S/4HANA) for ERP, Veeva Vault for regulatory and document management, LIMS for laboratory information systems, Power BI for analytics, and Siemens automation (S7-1200, WinCC) for production control.